In a constantly evolving world, rapidly growing populations coupled with urbanization and industrialization are leading to an ever-increasing demand for energy. The challenge today lies in meeting these energy requirements while keeping global warming in check—a condition which fossil fuels do not fulfil. In an effort to mitigate the environmental degradation and natural resource depletion
0 Comments
Rapamycin production and growth of the SRMK07 strain The rapamycin-overproducing mutant, S. rapamycinicus SRMK07, produced approximately 207 mg/L rapamycin, or around fourfold more rapamycin than the NRRL 5491 strain (Fig. 1a). Despite the significant improvement in the rapamycin production, the SRMK07 strain showed almost normal growth in comparison to the wild-type (Fig. 1b). The wild-type and the SRMK07
0 Comments
European investment company Gimv has launched its fifth investment platform with a focus on venture capital investments in innovative life sciences companies. Gimv said after growth in its existing healthcare platform, a dedicated life sciences platform will strengthen its role in the international life science venture capital ecosystem. The company added its key investment focus
0 Comments
Thought LeadersHenry FingerhutSenior Policy Analyst for Science & InnovationTony Blair Institute for Global Change In this interview, News-Medical speaks to Henry Fingerhut, Senior Policy Analyst for Science & Innovation at the Tony Blair Institute for Global Change, about genomic surveillance and its associated opportunities and challenges. In collaboration with Professor Derrick Crook of Oxford’s Nuffield
0 Comments
The companies will focus on the development of biomarkers for chronic diseases Nordic Bioscience has announced the strengthening of its ongoing collaboration with Roche for the development of proprietary biomarkers involved in tissue breakdown and build-up. Nordic typically concentrates on extra cellular matrix biomarker development, providing objective decision-making for compound selection in clinical trials. As
0 Comments
In a recent study posted to the medRxiv* preprint server, researchers assessed whether non-invasive estimation of the ratio of arterial oxygen partial pressure (PaO2) to the fractional inspired oxygen (Fi O2), i.e., the P/F ratio could measure overt and occult hypoxemia in coronavirus disease 2019 (COVID-19) patients. Study: Overt and occult hypoxemia in patients hospitalized
0 Comments
Mathematical modeling—which combines math, statistics, computing and data—is a critical tool for public health professionals, who use it to study how diseases spread, predict the future course of outbreaks and evaluate strategies for controlling epidemics. Mathematical modeling—which combines math, statistics, computing and data—is a critical tool for public health professionals, who use it to study
0 Comments
Governments around the world are redefining dual-use and critical technologies with reference to the politics of the moment, economic competitiveness, and the current distributions of global power. It has never been more important for synthetic biology practitioners to achieve coherence in the language they use in presenting the discipline to policymakers at the national and
0 Comments
It’s the first official Beyond Biotech podcast! And this week, we have three interviews. We talked with Ros Deegan, CEO of OMass; David Solomon, CEO of PharNext; and two people from Forbion, Sander Slootweg, managing partner, and Dirk Mertens, general partner. Forbion European life sciences venture capital firm Forbion, has announced the first €470M ($500M)
0 Comments
Researchers announced early tests of a new potato processing technique designed to make our bodies digest potato starch more slowly. Laboratory demonstrations show that the approach blocks certain digestive enzymes from reaching the potato starch as quickly, leading to a more controlled release of dietary glucose. There is a perception that potato foods are unhealthy
0 Comments
A new perspective by researchers from the American Cancer Society (ACS) and the University of Texas Health Science Center at San Antonio shows the high burden of breast cancer mortality in African American (Black) women versus White women began in the United States in the 1980’s. At that time, breast cancer screening (mammography) and treatments
0 Comments
Credit: Jan Willem Pieneman La bataille de Waterloo (1824, Rijksmuseum, Amsterdam) de Jan Willem Pieneman (1779-1853) Were the bones of fallen Battle of Waterloo soldiers sold as fertilizer? As very few human remains have been found from what was such a bloodied affair, killing thousands, it’s a conclusion that a new study suggests is most
0 Comments
Molecular cloning, mutagenesis, and screening The mBlueberry2 gene was synthesized de novo by Tsingke Biotechnology Co., Ltd. based on the sequence reported in the original publication25. Plasmids encoding mScarlet, EBFP2, and mTagBFP2 were acquired from Addgene. Synthetic DNA oligonucleotides used for cloning were purchased from Tsingke Biotechnology Co., Ltd. PrimeStar Max master mix (Clontech) was
0 Comments
French biotech company ImCheck has announced funding of €96 million ($101.5 million) to investigate antibody drugs with the ability to activate the powerful immune cells called gamma delta T (gdT).  The Marseille-based company hopes it will reach a wider range of cancer immunotherapy with the antibody drugs that include a lead candidate in the development
0 Comments
Therapy represents the first STAMP inhibitor for patients with chronic myeloid leukaemia Novartis UK has announced that Scemblix – also known as asciminib – has been granted marketing authorisation in the UK by the Medicines and Healthcare products Regulatory Agency (MHRA). The treatment involves patients with Philadelphia chromosome-positive chronic myeloid leukaemia (Ph+ CML) in chronic
0 Comments